Market Cap 65.68B
Revenue (ttm) 9.26B
Net Income (ttm) 2.49B
EPS (ttm) N/A
PE Ratio 24.21
Forward PE 23.68
Profit Margin 26.86%
Debt to Equity Ratio 1.32
Volume 2,663,323
Avg Vol 3,043,106
Day's Range N/A - N/A
Shares Out 443.18M
Stochastic %K 19%
Beta 0.89
Analysts Strong Sell
Price Target $193.71

Company Profile

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health products in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermato...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 973 822 7000
Address:
10 Sylvan Way, Parsippany, United States
highnihilism
highnihilism Sep. 16 at 5:15 PM
XLV: Health Care Select → $ALGN Align $SYK Stryker $ZTS Zoetis $BDX Becton Dickinson $DGX Quest Diagnostics
0 · Reply
highnihilism
highnihilism Sep. 16 at 4:25 PM
S&P 500 → $JKHY Jack Henry & Associates $ZTS Zoetis $SWKS Skyworks Solutions $MHK Mohawk Industries $APTV Aptiv
0 · Reply
ZacksResearch
ZacksResearch Sep. 15 at 2:32 PM
$ZTS gearing up for a game-changer in feline care? With the EU potentially approving Portela in the fourth quarter of 2025, Zoetis could soon offer the first long-acting anti-NGF mAb therapy for cats, addressing a major unmet need in feline osteoarthritis pain management. Discover what this could mean for ZTS investors 👉 https://www.zacks.com/stock/news/2751505/zoetis-gains-cvmp-backing-for-portela-eyes-eu-approval-in-cat-oa-pain?cid=sm-stocktwits-2-2751505-body-12400&ADID=SYND_STOCKTWITS_TWEET_2_2751505_BODY_12400
0 · Reply
ZacksResearch
ZacksResearch Sep. 15 at 1:32 PM
$ZTS making moves in animal health — EU approval on deck? CVMP just gave a positive opinion for Portela, Zoetis’ long-acting OA pain therapy for cats, with the final decision expected in late 2025. Full breakdown here 👉 https://www.zacks.com/stock/news/2751505/zoetis-gains-cvmp-backing-for-portela-eyes-eu-approval-in-cat-oa-pain?cid=sm-stocktwits-2-2751505-teaser-12380&ADID=SYND_STOCKTWITS_TWEET_2_2751505_TEASER_12380
0 · Reply
ZacksResearch
ZacksResearch Sep. 10 at 3:42 PM
$PAHC has soared 101.1% in the past year! 🚀 Is it time to double down? 🔹 Animal Health sales up 53% in fiscal Q4, boosted by $ZTS acquisition and strong international demand 🔹 Mineral Nutrition sees growth with increased demand for copper and trace minerals 🔹 Solid solvency with only $16M in short-term debt Full insights on this Zacks Rank #1 stock here 👉 https://www.zacks.com/stock/news/2749278/heres-why-you-should-add-pahc-stock-to-your-portfolio-right-now?cid=sm-stocktwits-2-2749278-body-11742&ADID=SYND_STOCKTWITS_TWEET_2_2749278_BODY_11742
0 · Reply
NVDAMillionaire
NVDAMillionaire Sep. 10 at 9:10 AM
$ZTS Great piece that accurately captures ZTS's current position. So if you want to refresh your understanding of ZTS or learn about ZTS for the first time, this is essential reading. https://beyondspx.com/quote/ZTS/analysis/zoetis-innovation-s-enduring-power-amidst-competitive-currents-nyse-zts
1 · Reply
JarvisFlow
JarvisFlow Sep. 9 at 1:20 PM
Argus Research has adjusted their stance on Zoetis ( $ZTS ), setting the rating to Buy with a target price of 190.
0 · Reply
Jblack500
Jblack500 Sep. 9 at 1:29 AM
$ZTS so who were those shares sold to at 146.50 on the crazy candle today? That wasn't normal price movement.
0 · Reply
Lausbub891208
Lausbub891208 Sep. 8 at 5:13 PM
$ZTS scamstreet
0 · Reply
711Coffee
711Coffee Sep. 8 at 5:11 PM
$ZTS btfd
0 · Reply
Latest News on ZTS
Zoetis: A Solid Dividend Growth Investment For The Long Haul

Sep 1, 2025, 4:14 AM EDT - 15 days ago

Zoetis: A Solid Dividend Growth Investment For The Long Haul


Zoetis: Why I Decided To Invest In The Stock

Aug 25, 2025, 1:45 AM EDT - 22 days ago

Zoetis: Why I Decided To Invest In The Stock


Zoetis Announces Pricing of $1.85 Billion of Senior Notes

Aug 11, 2025, 6:48 PM EDT - 5 weeks ago

Zoetis Announces Pricing of $1.85 Billion of Senior Notes


Zoetis Inc. (ZTS) Q2 2025 Earnings Call Transcript

Aug 5, 2025, 12:20 PM EDT - 6 weeks ago

Zoetis Inc. (ZTS) Q2 2025 Earnings Call Transcript


Zoetis: Growth To Continue Thanks To Companion Animals

Jul 3, 2025, 1:11 AM EDT - 2 months ago

Zoetis: Growth To Continue Thanks To Companion Animals


Top Stock Movers Now: Jabil, Oracle, Zoetis, and More

Jun 18, 2025, 12:01 PM EDT - 3 months ago

Top Stock Movers Now: Jabil, Oracle, Zoetis, and More

JBL ORCL


Zoetis Releases 2024 Sustainability Progress Update

Jun 5, 2025, 9:00 AM EDT - 3 months ago

Zoetis Releases 2024 Sustainability Progress Update


Top 15 High-Growth Dividend Stocks For June 2025

Jun 2, 2025, 10:00 AM EDT - 3 months ago

Top 15 High-Growth Dividend Stocks For June 2025

DKS DPZ GPN INTU KLAC LRCX MPWR


Dr. Mark Stetter Elected to Zoetis Board of Directors

May 22, 2025, 4:15 PM EDT - 4 months ago

Dr. Mark Stetter Elected to Zoetis Board of Directors


Zoetis Declares Third Quarter 2025 Dividend

May 21, 2025, 4:15 PM EDT - 4 months ago

Zoetis Declares Third Quarter 2025 Dividend


Zoetis to Participate in Upcoming Investor Conferences

May 15, 2025, 8:30 AM EDT - 4 months ago

Zoetis to Participate in Upcoming Investor Conferences


Zoetis' Q1: Market Overreaction Or Justified Drop?

May 9, 2025, 12:16 PM EDT - 4 months ago

Zoetis' Q1: Market Overreaction Or Justified Drop?


Zoetis Inc. (ZTS) Q1 2025 Earnings Call Transcript

May 6, 2025, 12:48 PM EDT - 4 months ago

Zoetis Inc. (ZTS) Q1 2025 Earnings Call Transcript


Zoetis Announces First Quarter 2025 Results

May 6, 2025, 7:00 AM EDT - 4 months ago

Zoetis Announces First Quarter 2025 Results


Zoetis: Unleashing Margin Expansion; Initiate Strong Buy

May 4, 2025, 8:53 AM EDT - 4 months ago

Zoetis: Unleashing Margin Expansion; Initiate Strong Buy


Elanco vs Zoetis stock: Sarat Sethi picks a side

Apr 24, 2025, 7:54 AM EDT - 5 months ago

Elanco vs Zoetis stock: Sarat Sethi picks a side


Trade Tracker: Sarat Sethi buys Zoetis and sells Elanco

Apr 23, 2025, 1:16 PM EDT - 5 months ago

Trade Tracker: Sarat Sethi buys Zoetis and sells Elanco

ELAN


Zoetis: Focusing On The High Margin Segments

Mar 13, 2025, 4:35 PM EDT - 6 months ago

Zoetis: Focusing On The High Margin Segments


Zoetis CEO on bird flu vaccine

Feb 18, 2025, 12:25 PM EST - 7 months ago

Zoetis CEO on bird flu vaccine


Zoetis CEO says Avian Flu vaccine for poultry gets USDA approval

Feb 13, 2025, 5:12 PM EST - 7 months ago

Zoetis CEO says Avian Flu vaccine for poultry gets USDA approval


Zoetis Inc. (ZTS) Q4 2024 Earnings Call Transcript

Feb 13, 2025, 12:27 PM EST - 7 months ago

Zoetis Inc. (ZTS) Q4 2024 Earnings Call Transcript


highnihilism
highnihilism Sep. 16 at 5:15 PM
XLV: Health Care Select → $ALGN Align $SYK Stryker $ZTS Zoetis $BDX Becton Dickinson $DGX Quest Diagnostics
0 · Reply
highnihilism
highnihilism Sep. 16 at 4:25 PM
S&P 500 → $JKHY Jack Henry & Associates $ZTS Zoetis $SWKS Skyworks Solutions $MHK Mohawk Industries $APTV Aptiv
0 · Reply
ZacksResearch
ZacksResearch Sep. 15 at 2:32 PM
$ZTS gearing up for a game-changer in feline care? With the EU potentially approving Portela in the fourth quarter of 2025, Zoetis could soon offer the first long-acting anti-NGF mAb therapy for cats, addressing a major unmet need in feline osteoarthritis pain management. Discover what this could mean for ZTS investors 👉 https://www.zacks.com/stock/news/2751505/zoetis-gains-cvmp-backing-for-portela-eyes-eu-approval-in-cat-oa-pain?cid=sm-stocktwits-2-2751505-body-12400&ADID=SYND_STOCKTWITS_TWEET_2_2751505_BODY_12400
0 · Reply
ZacksResearch
ZacksResearch Sep. 15 at 1:32 PM
$ZTS making moves in animal health — EU approval on deck? CVMP just gave a positive opinion for Portela, Zoetis’ long-acting OA pain therapy for cats, with the final decision expected in late 2025. Full breakdown here 👉 https://www.zacks.com/stock/news/2751505/zoetis-gains-cvmp-backing-for-portela-eyes-eu-approval-in-cat-oa-pain?cid=sm-stocktwits-2-2751505-teaser-12380&ADID=SYND_STOCKTWITS_TWEET_2_2751505_TEASER_12380
0 · Reply
ZacksResearch
ZacksResearch Sep. 10 at 3:42 PM
$PAHC has soared 101.1% in the past year! 🚀 Is it time to double down? 🔹 Animal Health sales up 53% in fiscal Q4, boosted by $ZTS acquisition and strong international demand 🔹 Mineral Nutrition sees growth with increased demand for copper and trace minerals 🔹 Solid solvency with only $16M in short-term debt Full insights on this Zacks Rank #1 stock here 👉 https://www.zacks.com/stock/news/2749278/heres-why-you-should-add-pahc-stock-to-your-portfolio-right-now?cid=sm-stocktwits-2-2749278-body-11742&ADID=SYND_STOCKTWITS_TWEET_2_2749278_BODY_11742
0 · Reply
NVDAMillionaire
NVDAMillionaire Sep. 10 at 9:10 AM
$ZTS Great piece that accurately captures ZTS's current position. So if you want to refresh your understanding of ZTS or learn about ZTS for the first time, this is essential reading. https://beyondspx.com/quote/ZTS/analysis/zoetis-innovation-s-enduring-power-amidst-competitive-currents-nyse-zts
1 · Reply
JarvisFlow
JarvisFlow Sep. 9 at 1:20 PM
Argus Research has adjusted their stance on Zoetis ( $ZTS ), setting the rating to Buy with a target price of 190.
0 · Reply
Jblack500
Jblack500 Sep. 9 at 1:29 AM
$ZTS so who were those shares sold to at 146.50 on the crazy candle today? That wasn't normal price movement.
0 · Reply
Lausbub891208
Lausbub891208 Sep. 8 at 5:13 PM
$ZTS scamstreet
0 · Reply
711Coffee
711Coffee Sep. 8 at 5:11 PM
$ZTS btfd
0 · Reply
StockAutoPro
StockAutoPro Sep. 5 at 9:56 PM
$ZTS: Buy target $150.94 Sell target $160.59 Strong pet adoption rates during pandemic may boost animal health sector revenues.
0 · Reply
StockAutoPro
StockAutoPro Sep. 3 at 4:31 PM
$ZTS: Buy target $150.88 Sell target $160.52 Robust product pipeline and solid demand growth make this ZTS sector stock a potential buy.
0 · Reply
StockAutoPro
StockAutoPro Sep. 3 at 6:17 AM
$ZTS: Buy target $150.88 Sell target $160.52 Strong earnings growth makes this pet pharmaceutical company a promising long-term investment.
0 · Reply
DividendPower
DividendPower Sep. 1 at 11:08 AM
Zoetis: A Solid Dividend Growth Investment For The Long Haul $ZTS @SeekingAlpha https://seekingalpha.com/article/4818252-zoetis-a-solid-dividend-growth-investment-for-the-long-haul
0 · Reply
eWhispers
eWhispers Aug. 30 at 4:44 PM
The Pharmaceuticals are among the leaders this quarter, with 86% of $IHE outperforming the S&P 500 $SPY since reporting earnings. The only laggards among the group are $PFE $ZTS $RPRX PBH and OGN https://www.earningswhispers.com/wrs
2 · Reply
MyChicago
MyChicago Aug. 29 at 7:35 PM
$ZOMDF Headed up, little by little $WOOF had a great day and $ZTS . Zomedica, keep climbing.
0 · Reply
MyChicago
MyChicago Aug. 29 at 3:17 PM
$ZOMDF Nice time to grab your shares. $WOOF Is looking good, and also $ZTS
0 · Reply
MyChicago
MyChicago Aug. 29 at 2:25 PM
$ZOMDF $WOOF $ZTS Animal health care all up today.
0 · Reply
DividendPower
DividendPower Aug. 26 at 9:51 PM
The 2025 Dividend Contenders: A Complete List and Financial Insights - Updated 08/26/25 https://www.dividendpower.org/2025-dividend-contenders/ $AL $MATX $MPLX $AVT $ZTS
0 · Reply
StockAutoPro
StockAutoPro Aug. 24 at 6:37 PM
$ZTS: Buy target $154.62 Sell target $164.45 Strong pet adoption rates during pandemic could drive growth for major animal health company.
0 · Reply
br0alX4
br0alX4 Aug. 21 at 11:27 AM
$ZTS People ignored this quality stock? -P/E and FWD P/E (26.60 and 23.65) - low -P/FCF 31.29 - low -ROIC 28.06 - high They also raised its full-year guidance. So...I think it’s a good value play!
0 · Reply